Sanofi announces an investment of €40 million in its Lyon Gerland bioproduction site, consolidating its role as a strategic platform dedicated to immunology. Sanofi thus continues to support the production in France of Thymoglubulin, a drug used in particular in transplantation, and anticipates future needs in …
Emcure Pharmaceuticals, a leading pharma company with a strong focus on women’s healthcare, achieved a significant milestone on World Diabetes Day, making it to the Asia Book of Records for orchestrating the largest virtual diabetes awareness campaign focused on women’s health. The record-setting initiative brought together …
Global pharma major Lupin Limited (Lupin) announced the launch of Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multiple-Dose Vials in the United States, after having received an approval from the United Food and Drug Administration (U.S. FDA). …
Pious Laboratories Pvt. Ltd. is centrally located with our operational laboratory headquarters in Indore, Madhya Pradesh (India) being centrally connected pan-India with collection centres spread to serve our customers across the nation. We are an ISO 17025: 2017accredited (NABL) laboratory (For Food, Water & Pharma) &APEDA. …
Jagsonpal Pharmaceuticals Limited Jagsonpal Pharmaceuticals Limited had informed that the company had entered into an agreement to sell to divest the Faridabad Facility. The company has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration …
Pfizer announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD, as Chief Scientific Officer and President, Research & Development effective January 1, 2025. Dr. Boshoff, who most recently served as Chief Oncology Officer and Executive Vice President, …
Glenmark Pharmaceuticals Inc, USA on Wednesday said it has launched Travoprost ophthalmic solution used in the treatment of glaucoma. The Travoprost ophthalmic solution ( 0.004 per cent ionic buffered solution) is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z ophthalmic solution USP, 0.004 …
Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
error: Content is protected !!
